{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T08:33:28Z","timestamp":1777710808110,"version":"3.51.4"},"reference-count":50,"publisher":"S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMedLife"],"DOI":"10.25122\/jml-2023-0317","type":"journal-article","created":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T03:24:25Z","timestamp":1715397865000},"page":"1615-1621","source":"Crossref","is-referenced-by-count":9,"title":["Effects of combined metformin and cabergoline versus metformin alone on ovarian and hormonal activities in Iraqi patients with PCOS and hyperprolactinemia: a randomized clinical trial"],"prefix":"10.25122","volume":"16","author":[{"given":"Hayder Adnan","family":"Fawzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Pharmacy, Al-Mustafa University College, Baghdad, Iraq","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inas Naser","family":"Hamad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Pharmacy, Maternity and Pediatric Teaching Hospital, Al-Qadisiyah, Iraq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinaa Abdul Amir","family":"Kadhim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Pharmacology, College of Medicine, University of Al-Qadisiyah, Al-Qadisiyah, Iraq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoroq Mohammed","family":"AL-Temimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Pharmacology, College of Medicine, University of Al-Qadisiyah, Al-Qadisiyah, Iraq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bassim","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Pharmacology, College of Medicine, University of Al-Qadisiyah, Al-Qadisiyah, Iraq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asma","family":"Swadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Pharmacology, College of Medicine, University of Al-Qadisiyah, Al-Qadisiyah, Iraq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10755","published-online":{"date-parts":[[2023,11]]},"reference":[{"issue":"8","key":"ref1","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1210\/js.2019-00078","article-title":"Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls","volume":"3","author":"Witchel SF Oberfield SE Pe\u00f1a AS","year":"2019","unstructured":"1. Witchel SF Oberfield SE Pe\u00f1a AS Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls J Endocr Soc 201938154573 10.1210\/js.2019-00078","journal-title":"J Endocr Soc"},{"issue":"2","key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23020583","article-title":"Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing","volume":"23","author":"Sadeghi HM Adeli I Calina D Docea AO","year":"2022","unstructured":"2. Sadeghi HM Adeli I Calina D Docea AO  Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing Int J Mol Sci 202223210.3390\/ijms23020583","journal-title":"Int J Mol Sci"},{"issue":"6","key":"ref3","first-page":"336","article-title":"Polycystic ovary syndrome: a review of treatment options with a focus on pharmacological approaches","volume":"38","author":"Ndefo UA Eaton A Green MR","year":"2013","unstructured":"3. Ndefo UA Eaton A Green MR Polycystic ovary syndrome: a review of treatment options with a focus on pharmacological approaches P t 201338633655","journal-title":"P t"},{"issue":"4","key":"ref4","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1097\/GRF.0b013e3182353c98","article-title":"Polycystic ovary syndrome: current infertility management","volume":"54","author":"Aubuchon M Legro RS","year":"2011","unstructured":"4. Aubuchon M Legro RS Polycystic ovary syndrome: current infertility management Clin Obstet Gynecol 201154467584 10.1097\/GRF.0b013e3182353c98","journal-title":"Clin Obstet Gynecol"},{"issue":"4","key":"ref5","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1097\/AOG.0b013e3181bd12cb","article-title":"108: Polycystic ovary syndrome","volume":"114","author":"ACOG Practice Bulletin No","year":"2009","unstructured":"5. ACOG Practice Bulletin No 108: Polycystic ovary syndrome Obstet Gynecol 20091144936 10.1097\/AOG.0b013e3181bd12cb","journal-title":"Obstet Gynecol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2147\/dhps.s4388","article-title":"Polycystic ovary syndrome and its impact on women's quality of life: More than just an endocrine disorder","volume":"1","author":"Brady C Mousa SS Mousa SA","year":"2009","unstructured":"6. Brady C Mousa SS Mousa SA Polycystic ovary syndrome and its impact on women's quality of life: More than just an endocrine disorder Drug Healthc Patient Saf 20091915 10.2147\/dhps.s4388","journal-title":"Drug Healthc Patient Saf"},{"issue":"2","key":"ref7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4103\/jpbs.Jpbs_1_18","article-title":"Polycystic Ovarian Syndrome-Related Depression in Adolescent Girls: A Review","volume":"10","author":"Sadeeqa S Mustafa T Latif S","year":"2018","unstructured":"7. Sadeeqa S Mustafa T Latif S Polycystic Ovarian Syndrome-Related Depression in Adolescent Girls: A Review J Pharm Bioallied Sci 201810255910.4103\/jpbs.Jpbs_1_18","journal-title":"J Pharm Bioallied Sci"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jclinepi.2019.03.014","article-title":"A benefit-harm analysis of adding basal insulin vs sulfonylurea to metformin to manage type II diabetes mellitus in people with multiple chronic conditions","volume":"113","author":"Bennett WL Aschmann HE Puhan MA Robbins CW","year":"2019","unstructured":"8. Bennett WL Aschmann HE Puhan MA Robbins CW  A benefit-harm analysis of adding basal insulin vs sulfonylurea to metformin to manage type II diabetes mellitus in people with multiple chronic conditions J Clin Epidemiol 20191139210010.1016\/j.jclinepi.2019.03.014","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"ref9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1210\/jcem.85.1.6293","article-title":"Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation","volume":"85","author":"Moghetti P Castello R Negri C Tosi F","year":"2000","unstructured":"9. Moghetti P Castello R Negri C Tosi F  Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation J Clin Endocrinol Metab 200085113946 10.1210\/jcem.85.1.6293","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"ref10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1042\/cs20110386","article-title":"Cellular and molecular mechanisms of metformin: an overview","volume":"122","author":"Viollet B Guigas B Sanz Garcia N Leclerc J","year":"2012","unstructured":"10. Viollet B Guigas B Sanz Garcia N Leclerc J  Cellular and molecular mechanisms of metformin: an overview Clin Sci (Lond) 2012122625370 10.1042\/cs20110386","journal-title":"Clin Sci (Lond)"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"116818","DOI":"10.1016\/j.lfs.2019.116818","article-title":"Pharmacokinetic interactions between metformin and berberine in rats: Role of oral administration sequences and microbiota","volume":"235","author":"Lyu Y Zhang Y Yang M Lin L","year":"2019","unstructured":"11. Lyu Y Zhang Y Yang M Lin L  Pharmacokinetic interactions between metformin and berberine in rats: Role of oral administration sequences and microbiota Life Sci 201923511681810.1016\/j.lfs.2019.116818","journal-title":"Life Sci"},{"issue":"4","key":"ref12","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/dom.12854","article-title":"Understanding and overcoming metformin gastrointestinal intolerance","volume":"19","author":"Bonnet F Scheen A","year":"2017","unstructured":"12. Bonnet F Scheen A Understanding and overcoming metformin gastrointestinal intolerance Diabetes Obes Metab 201719447381 10.1111\/dom.12854","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"ref13","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/j.1463-1326.2004.00448.x","article-title":"Metformin revisited: re-evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents","volume":"7","author":"Goodarzi MO Bryer-Ash M","year":"2005","unstructured":"13. Goodarzi MO Bryer-Ash M Metformin revisited: re-evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents Diabetes Obes Metab 20057665465 10.1111\/j.1463-1326.2004.00448.x","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052734","article-title":"The Role of Chronic Inflammation in Polycystic Ovarian Syndrome-A Systematic Review and Meta-Analysis","volume":"22","author":"Aboeldalyl S James C Seyam E Ibrahim EM","year":"2021","unstructured":"14. Aboeldalyl S James C Seyam E Ibrahim EM  The Role of Chronic Inflammation in Polycystic Ovarian Syndrome-A Systematic Review and Meta-Analysis Int J Mol Sci 2021225 10.3390\/ijms22052734","journal-title":"Int J Mol Sci"},{"issue":"2","key":"ref15","first-page":"93","article-title":"Cabergoline plus metformin therapy effects on menstrual irregularity and androgen system in polycystic ovary syndrome women with hyperprolactinemia","volume":"13","author":"Ghaneei A Jowkar A Hasani Ghavam MR Ghaneei ME","year":"2015","unstructured":"15. Ghaneei A Jowkar A Hasani Ghavam MR Ghaneei ME Cabergoline plus metformin therapy effects on menstrual irregularity and androgen system in polycystic ovary syndrome women with hyperprolactinemia Iran J Reprod Med 201513293100","journal-title":"Iran J Reprod Med"},{"issue":"1","key":"ref16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s12020-012-9857-y","article-title":"Effect of cabergoline on insulin sensitivity, inflammation, and carotid intima media thickness in patients with prolactinoma","volume":"44","author":"Inancli SS Usluogullari A Ustu Y Caner S","year":"2013","unstructured":"16. Inancli SS Usluogullari A Ustu Y Caner S  Effect of cabergoline on insulin sensitivity, inflammation, and carotid intima media thickness in patients with prolactinoma Endocrine 2013441193910.1007\/s12020-012-9857-y","journal-title":"Endocrine"},{"issue":"3","key":"ref17","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/path.1642","article-title":"Frequent overexpression of multiple ErbB receptors by head and neck squamous cell carcinoma contrasts with rare antibody immunity in patients","volume":"204","author":"Bei R Budillon A Masuelli L Cereda V","year":"2004","unstructured":"17. Bei R Budillon A Masuelli L Cereda V  Frequent overexpression of multiple ErbB receptors by head and neck squamous cell carcinoma contrasts with rare antibody immunity in patients J Pathol 2004204331725 10.1002\/path.1642","journal-title":"J Pathol"},{"issue":"4","key":"ref18","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4103\/jhrs.JHRS_95_18","article-title":"The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review","volume":"13","author":"Deswal R Narwal V Dang A Pundir CS","year":"2020","unstructured":"18. Deswal R Narwal V Dang A Pundir CS The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review J Hum Reprod Sci 20201342617110.4103\/jhrs.JHRS_95_18","journal-title":"J Hum Reprod Sci"},{"key":"ref19","article-title":"Biostatistics: a foundation for analysis in the health sciences","author":"Daniel WW Cross CL","year":"2018","unstructured":"19. Daniel WW Cross CL Biostatistics: a foundation for analysis in the health sciences 2018 Wiley","journal-title":""},{"issue":"3","key":"ref20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/nt.0000000000000092","article-title":"Body Mass Index: Obesity, BMI, and Health: A Critical Review","volume":"50","author":"Nuttall FQ","year":"2015","unstructured":"20. Nuttall FQ Body Mass Index: Obesity, BMI, and Health: A Critical Review Nutr Today 20155031172810.1097\/nt.0000000000000092","journal-title":"Nutr Today"},{"issue":"7","key":"ref21","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.tcm.2019.08.010","article-title":"Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention","volume":"30","author":"Osibogun O Ogunmoroti O Michos ED","year":"2020","unstructured":"21. Osibogun O Ogunmoroti O Michos ED Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention Trends Cardiovasc Med 2020307399404 10.1016\/j.tcm.2019.08.010","journal-title":"Trends Cardiovasc Med"},{"issue":"8","key":"ref22","doi-asserted-by":"publisher","first-page":"e28462","DOI":"10.7759\/cureus.28462","article-title":"Role of Metformin in the Management of Polycystic Ovarian Syndrome-Associated Acne: A Systematic Review","volume":"14","author":"Shamim H Jean M Umair M Muddaloor P","year":"2022","unstructured":"22. Shamim H Jean M Umair M Muddaloor P  Role of Metformin in the Management of Polycystic Ovarian Syndrome-Associated Acne: A Systematic Review Cureus 2022148e28462 10.7759\/cureus.28462","journal-title":"Cureus"},{"issue":"2","key":"ref23","first-page":"217","article-title":"Cabergoline (Dostinex) Effect on Weight Ovarian Function","volume":"6","author":"RJK A-A","year":"2017","unstructured":"23. RJK A-A Cabergoline (Dostinex) Effect on Weight Ovarian Function Fam Med Med Sci Res 201762217","journal-title":"Fam Med Med Sci Res"},{"issue":"5","key":"ref24","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s13224-017-1022-3","article-title":"Efficacy of Combined Cabergoline and Metformin Compared to Metformin Alone on Cycle Regularity in Patients with Polycystic Ovarian Disease with Hyperprolactinemia: A Randomized Clinical Trial","volume":"67","author":"Elsersy MAM","year":"2017","unstructured":"24. Elsersy MAM Efficacy of Combined Cabergoline and Metformin Compared to Metformin Alone on Cycle Regularity in Patients with Polycystic Ovarian Disease with Hyperprolactinemia: A Randomized Clinical Trial J Obstet Gynaecol India 2017675363910.1007\/s13224-017-1022-3","journal-title":"J Obstet Gynaecol India"},{"issue":"1","key":"ref25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13098-015-0094-4","article-title":"Metabolic abnormalities in patients with prolactinoma: response to treatment with cabergoline","volume":"7","author":"Pala NA Laway BA Misgar RA Dar RA","year":"2015","unstructured":"25. Pala NA Laway BA Misgar RA Dar RA Metabolic abnormalities in patients with prolactinoma: response to treatment with cabergoline Diabetol Metab Syndr 2015719910.1186\/s13098-015-0094-4","journal-title":"Diabetol Metab Syndr"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"515s","DOI":"10.1002\/j.1550-8528.1995.tb00221.x","article-title":"Dopamine receptor subtype agonists and feeding behavior","volume":"3","author":"Terry P Gilbert DB Cooper SJ","year":"1995","unstructured":"26. Terry P Gilbert DB Cooper SJ Dopamine receptor subtype agonists and feeding behavior Obes Res 19953 Suppl 4515s23s 10.1002\/j.1550-8528.1995.tb00221.x","journal-title":"Obes Res"},{"issue":"9253","key":"ref27","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/s0140-6736(00)03643-6","article-title":"Brain dopamine and obesity","volume":"357","author":"Wang GJ Volkow ND Logan J Pappas NR","year":"2001","unstructured":"27. Wang GJ Volkow ND Logan J Pappas NR  Brain dopamine and obesity Lancet 20013579253354710.1016\/s0140-6736(00)03643-6","journal-title":"Lancet"},{"issue":"2","key":"ref28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2165\/00023210-200216020-00001","article-title":"Atypical antipsychotic-induced diabetes mellitus: how strong is the evidence?","volume":"16","author":"Henderson DC","year":"2002","unstructured":"28. Henderson DC Atypical antipsychotic-induced diabetes mellitus: how strong is the evidence? CNS Drugs 20021627789 10.2165\/00023210-200216020-00001","journal-title":"CNS Drugs"},{"issue":"7","key":"ref29","first-page":"22","article-title":"Antipsychotic-induced weight gain: a review of the literature","volume":"62","author":"Allison DB Casey DE","year":"2001","unstructured":"29. Allison DB Casey DE Antipsychotic-induced weight gain: a review of the literature J Clin Psychiatry 20016272231","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"ref30","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1463-1326.2011.01534.x","article-title":"Randomized pilot study of cabergoline, a dopamine receptor agonist: effects on body weight and glucose tolerance in obese adults","volume":"14","author":"Gibson CD Karmally W McMahon DJ Wardlaw SL Korner J","year":"2012","unstructured":"30. Gibson CD Karmally W McMahon DJ Wardlaw SL Korner J Randomized pilot study of cabergoline, a dopamine receptor agonist: effects on body weight and glucose tolerance in obese adults Diabetes Obes Metab 20121443354010.1111\/j.1463-1326.2011.01534.x","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"ref31","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s13679-019-00335-3","article-title":"Metformin: Mechanisms in Human Obesity and Weight Loss","volume":"8","author":"Yerevanian A Soukas AA","year":"2019","unstructured":"31. Yerevanian A Soukas AA Metformin: Mechanisms in Human Obesity and Weight Loss Curr Obes Rep 2019821566410.1007\/s13679-019-00335-3","journal-title":"Curr Obes Rep"},{"issue":"1","key":"ref32","first-page":"85","article-title":"Effect of metformin on the level of anti-Mullerian hormone in therapy of polycystic ovary syndrome in obese women","volume":"66","author":"Grigoryan O Absatarova J Andreeva E Melnichenko G Dedov I","year":"2014","unstructured":"32. Grigoryan O Absatarova J Andreeva E Melnichenko G Dedov I Effect of metformin on the level of anti-Mullerian hormone in therapy of polycystic ovary syndrome in obese women Minerva Ginecol 2014661859","journal-title":"Minerva Ginecol"},{"issue":"2","key":"ref33","doi-asserted-by":"publisher","first-page":"143","DOI":"10.18502\/ijrm.v17i2.3992","article-title":"Evaluation of the metformin effects on Anti-M\u00fcllerian Hormone in women with polycystic ovarian syndrome: A double-blind randomized clinical trial","volume":"17","author":"Rahmanian M","year":"2019","unstructured":"33. Rahmanian M Evaluation of the metformin effects on Anti-M\u00fcllerian Hormone in women with polycystic ovarian syndrome: A double-blind randomized clinical trial Int J Reprod Biomed 20191721434 10.18502\/ijrm.v17i2.3992","journal-title":"Int J Reprod Biomed"},{"issue":"1","key":"ref34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/cen.13333","article-title":"The effects of dietary approaches to stop hypertension diet on weight loss, anti-M\u00fcllerian hormone and metabolic profiles in women with polycystic ovary syndrome: A randomized clinical trial","volume":"87","author":"Foroozanfard F Rafiei H Samimi M Gilasi HR","year":"2017","unstructured":"34. Foroozanfard F Rafiei H Samimi M Gilasi HR  The effects of dietary approaches to stop hypertension diet on weight loss, anti-M\u00fcllerian hormone and metabolic profiles in women with polycystic ovary syndrome: A randomized clinical trial Clin Endocrinol (Oxf) 201787151810.1111\/cen.13333","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"ref35","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/aogs.12605","article-title":"Impact of metformin on anti-M\u00fcllerian hormone in women with polycystic ovary syndrome: a secondary analysis of a randomized controlled trial","volume":"94","author":"Madsen HN Lauszus FF Trolle B Ingerslev HJ T\u00f8rring N","year":"2015","unstructured":"35. Madsen HN Lauszus FF Trolle B Ingerslev HJ T\u00f8rring N Impact of metformin on anti-M\u00fcllerian hormone in women with polycystic ovary syndrome: a secondary analysis of a randomized controlled trial Acta Obstet Gynecol Scand 20159455475110.1111\/aogs.12605","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/gye.17.1.51.56","article-title":"Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome","volume":"17","author":"Kazerooni T Dehghan-Kooshkghazi M","year":"2003","unstructured":"36. Kazerooni T Dehghan-Kooshkghazi M Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome Gynecol Endocrinol 2003171516","journal-title":"Gynecol Endocrinol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"5150684","DOI":"10.1155\/2020\/5150684","article-title":"The Effect of Metformin on Polycystic Ovary Syndrome in Overweight Women: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"2020","author":"Guan Y Wang D Bu H Zhao T Wang H","year":"2020","unstructured":"37. Guan Y Wang D Bu H Zhao T Wang H The Effect of Metformin on Polycystic Ovary Syndrome in Overweight Women: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Int J Endocrinol 202020205150684 10.1155\/2020\/5150684","journal-title":"Int J Endocrinol"},{"issue":"3","key":"ref38","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3109\/09513590.2011.583957","article-title":"Metformin versus lifestyle changes in treating women with polycystic ovary syndrome","volume":"28","author":"Curi DD Fonseca AM Marcondes JA Almeida JA","year":"2012","unstructured":"38. Curi DD Fonseca AM Marcondes JA Almeida JA  Metformin versus lifestyle changes in treating women with polycystic ovary syndrome Gynecol Endocrinol 2012283182510.3109\/09513590.2011.583957","journal-title":"Gynecol Endocrinol"},{"issue":"7421","key":"ref39","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1136\/bmj.327.7421.951","article-title":"Metformin in polycystic ovary syndrome: systematic review and meta-analysis","volume":"327","author":"Lord JM Flight IH Norman RJ","year":"2003","unstructured":"39. Lord JM Flight IH Norman RJ Metformin in polycystic ovary syndrome: systematic review and meta-analysis BMJ 200332774219513 10.1136\/bmj.327.7421.951","journal-title":"BMJ"},{"issue":"5","key":"ref40","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1046\/j.1365-2125.2002.01575.x","article-title":"Metformin does not enhance ovulation induction in clomiphene resistant polycystic ovary syndrome in clinical practice","volume":"53","author":"Sturrock ND Lannon B Fay TN","year":"2002","unstructured":"40. Sturrock ND Lannon B Fay TN Metformin does not enhance ovulation induction in clomiphene resistant polycystic ovary syndrome in clinical practice Br J Clin Pharmacol 20025354697310.1046\/j.1365-2125.2002.01575.x","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"ref41","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1097\/AOG.0b013e31816a4ed4","article-title":"Use of metformin in polycystic ovary syndrome: a meta-analysis","volume":"111","author":"Creanga AA Bradley HM McCormick C Witkop CT","year":"2008","unstructured":"41. Creanga AA Bradley HM McCormick C Witkop CT Use of metformin in polycystic ovary syndrome: a meta-analysis Obstet Gynecol 2008111495968 10.1097\/AOG.0b013e31816a4ed4","journal-title":"Obstet Gynecol"},{"issue":"2","key":"ref42","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.fertnstert.2007.12.002","article-title":"Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction, achievement of pregnancy, and live birth in Asian women with polycystic ovary syndrome: a randomized controlled trial","volume":"91","author":"Zain MM Jamaluddin R Ibrahim A Norman RJ","year":"2009","unstructured":"42. Zain MM Jamaluddin R Ibrahim A Norman RJ Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction, achievement of pregnancy, and live birth in Asian women with polycystic ovary syndrome: a randomized controlled trial Fertil Steril 20099125142110.1016\/j.fertnstert.2007.12.002","journal-title":"Fertil Steril"},{"issue":"6","key":"ref43","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1056\/NEJMoa063971","article-title":"Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome","volume":"356","author":"Legro RS Barnhart HX Schlaff WD Carr BR","year":"2007","unstructured":"43. Legro RS Barnhart HX Schlaff WD Carr BR  Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome N Engl J Med 2007356655166 10.1056\/NEJMoa063971","journal-title":"N Engl J Med"},{"issue":"5","key":"ref44","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/jcu.22006","article-title":"Effect of metformin treatment on endometrial vascular indices in anovulatory obese\/overweight women with polycystic ovarian syndrome using three-dimensional power doppler ultrasonography","volume":"41","author":"Mohsen IA Elkattan E Nabil H Khattab S","year":"2013","unstructured":"44. Mohsen IA Elkattan E Nabil H Khattab S Effect of metformin treatment on endometrial vascular indices in anovulatory obese\/overweight women with polycystic ovarian syndrome using three-dimensional power doppler ultrasonography J Clin Ultrasound 201341527582 10.1002\/jcu.22006","journal-title":"J Clin Ultrasound"},{"issue":"4","key":"ref45","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.4103\/mmj.mmj_294_18","article-title":"Effect of metformin treatment on ovarian stromal blood flow in women with polycystic ovary syndrome","volume":"32","author":"Abd EL-Sattar M EL-Kelany O EL-Halaby AE-D Esmaeel H","year":"2019","unstructured":"45. Abd EL-Sattar M EL-Kelany O EL-Halaby AE-D Esmaeel H Effect of metformin treatment on ovarian stromal blood flow in women with polycystic ovary syndrome Menouf Med J 201932413715 10.4103\/mmj.mmj_294_18","journal-title":"Menouf Med J"},{"issue":"11","key":"ref46","doi-asserted-by":"publisher","first-page":"6072","DOI":"10.1210\/jc.2005-0965","article-title":"Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study","volume":"90","author":"Orio F Jr Palomba S Cascella T De Simone B","year":"2005","unstructured":"46. Orio F Jr Palomba S Cascella T De Simone B  Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study J Clin Endocrinol Metab 200590116072610.1210\/jc.2005-0965","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"ref47","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/s0015-0282(00)01695-2","article-title":"Endometrial receptivity in an in vitro fertilization program as assessed by spiral artery blood flow, endometrial thickness, endometrial volume, and uterine artery blood flow","volume":"75","author":"Schild RL Knobloch C Dorn C Fimmers R","year":"2001","unstructured":"47. Schild RL Knobloch C Dorn C Fimmers R  Endometrial receptivity in an in vitro fertilization program as assessed by spiral artery blood flow, endometrial thickness, endometrial volume, and uterine artery blood flow Fertil Steril 2001752361610.1016\/s0015-0282(00)01695-2","journal-title":"Fertil Steril"},{"issue":"3","key":"ref48","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/uog.7314","article-title":"Endometrial blood flow is impaired in women with polycystic ovarian syndrome who are clinically hyperandrogenic","volume":"34","author":"Lam P Johnson I Raine-Fenning N","year":"2009","unstructured":"48. Lam P Johnson I Raine-Fenning N Endometrial blood flow is impaired in women with polycystic ovarian syndrome who are clinically hyperandrogenic Ultrasound Obstet Gynecol 200934332634 10.1002\/uog.7314","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"9","key":"ref49","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1056\/nejm199608293350902","article-title":"Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome","volume":"335","author":"Nestler JE Jakubowicz DJ","year":"1996","unstructured":"49. Nestler JE Jakubowicz DJ Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome N Engl J Med 199633596172310.1056\/nejm199608293350902","journal-title":"N Engl J Med"},{"issue":"5","key":"ref50","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.fertnstert.2004.04.046","article-title":"Characterizing the endometrium in unexplained and tubal factor infertility: a multiparametric investigation","volume":"82","author":"Edi-Osagie EC Seif MW Aplin JD Jones CJ","year":"2004","unstructured":"50. Edi-Osagie EC Seif MW Aplin JD Jones CJ  Characterizing the endometrium in unexplained and tubal factor infertility: a multiparametric investigation Fertil Steril 200482513798910.1016\/j.fertnstert.2004.04.046","journal-title":"Fertil Steril"}],"container-title":["Journal of Medicine and Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medandlife.org\/all-issues\/2023\/issue-11-2023\/original-article-issue-11-2023\/effects-of-combined-metformin-and-cabergoline-versus-metformin-alone-on-ovarian-and-hormonal-activities-in-iraqi-patients-with-pcos-and-hyperprolactinemia-a-randomized-clinical-trial\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T03:25:09Z","timestamp":1715397909000},"score":1,"resource":{"primary":{"URL":"https:\/\/medandlife.org\/all-issues\/2023\/issue-11-2023\/original-article-issue-11-2023\/effects-of-combined-metformin-and-cabergoline-versus-metformin-alone-on-ovarian-and-hormonal-activities-in-iraqi-patients-with-pcos-and-hyperprolactinemia-a-randomized-clinical-trial\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["JMedLife-16-1615"],"URL":"https:\/\/doi.org\/10.25122\/jml-2023-0317","relation":{},"ISSN":["1844-3117"],"issn-type":[{"value":"1844-3117","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11]]}}}